India Rejects HIV Drug Application By Abbott Laboratories

4 Jan 2011

India, over the New Year weekend, has rejected an unmerited HIV drug patent application by US drug giant Abbott Laboratories, paving the way for access to lifesaving medication for HIV patients across the world. Read full story here.

Join us to stay updated
and help make lifesaving medicines accessible to all